Onc Pharmacology Flashcards
[Drugs] inhibit NFkB to decrease the transcription of cytokines; therefore suppressing both B and T cell function
Glucocorticoids inhibit NFkB to decrease the transcription of cytokines; therefore suppressing both B and T cell function
Glucocorticoids can induce the demargination of WBCs producing an artificial _
Glucocorticoids can induce the demargination of WBCs producing an artificial leukocytosis
The risk of stopping glucocorticoids too suddenly is _
The risk of stopping glucocorticoids too suddenly is adrenal insufficiency
Name some side effects of glucocorticoids
- Cushing syndrome
- Osteoporosis
- Amenorrhea
- Hyperglycemia
- Diabetes
- Adrenocortical atrophy
- Peptic ulcers
- Cataracts
- Psychosis
- Avascular necrosis (femoral head)
_ and _ are the two calcineurin inhibitors
Cyclosporine and tacrolimus are the two calcineurin inhibitors
Cyclosporine binds _
Cyclosporine binds cyclophilin
Tacrolimus binds _
Tacrolimus binds FKBP
* FK506 binding protein
Calcineurin inhibitors block T cell activation by _
Calcineurin inhibitors block T cell activation by preventing IL-2 transcription
Calcineurin inhibitors cyclosporine and tacrolimus are both highly [toxic]
Calcineurin inhibitors cyclosporine and tacrolimus are both highly nephrotoxic
* They are also neurotoxic and increase the risk for diabetes
[Immunosuppressant] can cause hirsutism and gingival hyperplasia
Cyclosporine can cause hirsutism and gingival hyperplasia
_ is a protein downstream of the IL-2 receptor that regulates cell cycle progression and proliferation of T cells
mTOR is a protein downstream of the IL-2 receptor that regulates cell cycle progression and proliferation of T cells
[Drug] is an mTOR inhibitor, blocking T cell activation by preventing response to IL-2
Sirolimus is an mTOR inhibitor, blocking T cell activation by preventing response to IL-2
* It binds to FKBP
Sirolimus is also called _
Sirolimus is also called rapamycin
The most common use of sirolimus is _ given that it is not [toxic]
The most common use of sirolimus is kidney transplant rejection prophylaxis given that it is not nephrotoxic
Daclizumab is a _ antibody that blocks the IL-2 receptor
Daclizumab is an anti-CD25 antibody that blocks the IL-2 receptor
* CD25 is a component of the IL-2R